Thank you! The research is still in very early phases. We have found that it works very well in cells in a dish in the laboratory. We are now rigorously testing it in a HBV mouse model to see how effective it is, determine the optimal dose, how long the effect lasts and of course, we are making sure that it is safe and doesn’t cause any harm to the mice. If that all goes well, then we can start to think about trying it in humans in clinical trials - however, that is likely to be many years away.